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ugates. AAbstract Present study deals with homogeneous and one-pot synthesis of novel macromolecular
prodrugs (MPDs) of aspirin onto naturally occurring hydrophilic biopolymer pullulan. Pullulan-
aspirin conjugates were synthesized by using green carboxylic acid activating reagent 1,10-carbon-
yldiimidazole (CDI). The aspirin was ﬁrst reacted with CDI to prepare aspirin-imidazolide at RT
for 24 h which in situ reacted with pre-dissolved pullulan and the reaction preceded further for
24 h at 80 C under nitrogen. Degree of substitution (DS 0.32–0.40) of aspirin onto pullulan was
calculated from 1H NMR spectroscopy. Spectroscopic techniques conﬁrmed the high covalent drug
loading and purity. Thermal analysis has revealed that new MPDs of aspirin are thermally more
stable than pure aspirin. The activation energy, order and frequency factor of the degradation reac-
tions were calculated using Broido, Friedman and Chang models. The amphiphilic pullulan-aspirin
conjugates self-assembled in nanoparticles without further structural modiﬁcations at solvent inter-
face in the range of 500–680 nm as examined by transmission electron microscopy. These novel
pullulan-aspirin conjugates with masked COOH functional group could be potentially safe pro-
drugs for the stomach.
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Hydrophilic biopolymers, especially, glycopolymers are getting
greater attention nowadays for the formation of macromolec-
ular prodrugs (MPDs). Polysaccharides based MPD design is
widely accepted and proved for better pharmaceutical and
pharmacological properties (Callant and Schacht, 1990;
Hussain et al., 2011a,b; Vinsova and Vaverikova, 2008; Jain
et al., 2007). Almost all of the polysaccharides used for the
purpose are nontoxic, biocompatible and cheaper drug careers.ing Saud University.
on, characterization, thermal stability and nanoassemblies of
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.06.001
2 M.A. Hussain et al.A number of non-steroidal anti-inﬂammatory drugs (NSA-
IDs), antibiotics (Kumar et al., 2013; Sharma and Sharma,
2008) and anticancer agents (Duncan et al., 2001) have been
reported as polyglucan based prodrugs. By this approach,
some useful properties can be easily achieved, e.g., better phar-
macokinetic proﬁle, increased tolerance and reduction in dose
frequency. Additionally, MPD design reduces work load on
the kidney, provides wider drug distribution and sustained/de-
layed drug release (Sharma and Sharma, 2008).
Polysaccharide based prodrug design can be achieved by
simple conversion of hydroxyl groups to esters and amides after
reactions with drugs (Pappas et al., 2006; Sandrine et al., 2005;
Takakura, 1996). By these reactions, carboxylic acids or car-
boxylic acid containing drugs, e.g., NSAIDs can be attached
with the polymer backbones (Kim and Na, 2010; Park et al.,
2012; Babazadeh, 2006; Hussain et al., 2009, 2011a,b). Previ-
ously, acid chlorides and anhydrides (Hussain et al., 2010b,a)
of the drug molecules containing carboxylic acid and sulfonic
acid catalyzed products were allowed to react with hydroxyls
of polysaccharides. However, nowadays homogenous reaction
methodologies (Glasser et al., 2000; Shimoda et al., 2012; Lie-
bert et al., 2011) alongwith the use of in situ carboxylic acid acti-
vating reagents are the prodrug design strategies. Weak and
sensitive carboxylic acid containing drugs toward esteriﬁcation
reactions are ﬁrst activated with RCOOH acid activating re-
agents (Hussain and Heinze, 2008; Liebert et al., 2006) that in-
clude p-toluenesulfonyl chloride (Hussain et al., 2013), 1,10-
carbonyldiimidazole (CDI) (Hussain et al.,2004b), and iminium
chlorides (Hussain et al., 2004a), etc. CDI is one of the powerful
and safest reagents as imidazole generated in situ acts as a base
to neutralize acidic impurities. Themacromolecular drug conju-
gates are tuned in such a way to achieve amphiphilic nature of
the conjugates as a whole. Therefore, by tuning the degree of
substitution of pendant drug molecules, the resultant MPDs
self-assembled in nanoparticles. We have recently reported a
novel nanoparticulate drug design of aspirin onto a hydrophilic
biopolymer i.e., hydroxypropylmethylcellulose (HPMC) (Huss-
ain et al., 2011a,b). Moreover, nano-particulate HPMC-aspirin
conjugates have shown delayed release and improved
pharmacokinetics.
Our aim was to design pullulan based prodrugs of aspirin
and to study their properties. In addition to the synthesis of
nonionic, acid resistant, neutral, and biocompatible novel bio-
conjugates of aspirin, it offers safety to the stomach from
hyperacidity and colon targeted drug delivery. One can exploit
controlled/sustained release of these newly designed MPDs as
a future aspect of the present work. We were also focused to
study self-assembly of pullulan-aspirin conjugates in solution
without further structure modiﬁcation. Self-assembled nano-
particles, thermal degradation and kinetics of the novel poly-
meric aspirin conjugates are being reported for the ﬁrst time.
2. Experimental
2.1. Materials
Aspirin (US Pharmacopoeia standards) used was gifted by
Askari Pharmaceuticals, Pakistan. 1,10-Carbonyldiimazole
(CDI) was obtained from Aldrich while pullulan was pur-
chased from IL, USA. Analytical grade N,N-dimethylacet-Please cite this article in press as: Hussain, M.A. et al., Fabricati
novel pullulan-aspirin conjugates. Arabian Journal of Chemistryamide (DMA), anhydrous lithium chloride and other
chemicals were used as received from Fluka.
2.2. Instrumentation
The FTIR (KBr pellet technique) spectra (m, cm1) were ac-
quired on IR Prestige-21 (Shimadzu, Japan).
The 1H NMR spectra (d, ppm; DMSO-d6, NS 16) of pullu-
lan-aspirin conjugates were recorded on Bruker 400 MHz ma-
chine while for 13C NMR 5000 Scans were accumulated.
Thermal degradation studies were performed on a SDT Q
600 (TA Instruments, USA) thermal analyzer. The thermal
spectra were recorded at the onset of signiﬁcant weight loss un-
der nitrogen at a constant heating rate of 10 C/min from RT
up to 800 C.
The products were studied by transmission electron micros-
copy (TEM) for self-assemblies. TEM used was Philips 420
instrument with an acceleration voltage of 120 kV.
2.3. Dissolution of pullulan
Pullulan was dried under vacuum at 110 C before dissolution
for 1 h. Dry pullulan (2 g) was dissolved in DMA (30 mL) by
stirring at 90 C. Polymer was dissolved within 25 min with
optical clarity.
2.4. Synthesis of pullulan-aspirin conjugates 1, a typical example
Aspirin (2.22 g, 12.33 mmol) was dissolved in DMF (40 mL)
solvent and CDI (1.99 g, 12.33 mmol) was added in parts un-
der nitrogen atmosphere. Reaction mixture was stirred for
24 h at RT for the synthesis of reactive imidazolide of aspirin.
This reaction mixture was added slowly to the solution of
pullulan (2 g, 12.33 mmol) in DMA. Reaction mixture was
continuously stirred at 80 C for 24 h under nitrogen. Isolation
of the product was carried out by precipitation of reaction
mixture into 200 mL ethanol. The precipitates of sample 1
were washed thoroughly with ethanol in order to remove any
of the side products and un-reacted drug contents. Precipitates
of pullulan-aspirin conjugate 1 were dried under vacuum at
50 C. Similar reaction procedures were adopted for the rest
of pullulan-aspirin conjugates. Yield: 1.95 g (76%);
DS = 0.32 by 1H NMR spectroscopy; FTIR (KBr):
m= 3431 (OH), 2926 (aromatic C–H), 1740 (C‚O ester),
1462 (CH2) cm
1; 1H NMR (400 MHz, DMSO-d6, d): 1.98
(H-7), 3.35–5.70 (AGU-H-1-6), 6.94 (H-9,11), 7.50 (H-10),
7.86 (H-8) ppm; 13C NMR (DMSO-d6, d): 170.49 (C-8),
168.99 (C-7), 117.75 (C-1), 119.90 (C-3), 130.61 (C-5), 136.16
(C-6), 136.26 (C-4), 160.61 (C-2), 101.84 & 95.99 (C-10),
74.45-67.5 (C11–14), 60.56 (C-15), 21.08 (C-9) ppm.
2.5. Transmission electron microscopy
Nanoparticles of pullulan-aspirin conjugates 3 were prepared
using dialysis process. Sample 3 (20 mg) was taken in a typical
batch, dissolved in puriﬁed DMSO (5 mL). Dialysis process
was continued for 4 days against water along with constant
stirring. The nanoparticle suspension was concentrated. The
TEM samples were prepared using drop casting on carbonon, characterization, thermal stability and nanoassemblies of
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.06.001
Table 1 Reaction conditions and results of the esteriﬁcation of pullulan (2 g) using in situ activated aspirin with CDI at 80 C for 24 h.
Sample Mole ratioa Yield (g/%) DSb Solubility
1 1:1:1 1.95/76 0.32 Acetone, DMF, DMSO, DMA
2 1:2:2 2.10/79 0.36 Acetone, DMF, DMSO, DMA
3 1:3:3 2.25/81 0.38 Acetone, DMF, DMSO, DMA
4 1:6:6 2.29/81 0.40 Acetone, DMF, DMA
a AGU:aspirin:CDI.
b DS (degree of substitution) calculated by 1H NMR spectroscopy.
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Scheme 1 Synthesis of MPDs of aspirin with pullulan applying in situ activation of aspirin with CDI.
Figure 1 FTIR (KBr) spectrum of pullulan-aspirin conjugate 2.
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fore studying by TEM.
2.6. Thermal degradation kinetic analysis
The kinetics of thermal decomposition of pullulan-aspirin con-
jugates were examined by Friedman, Broido and Chang meth-
ods. Friedman kinetic model (Friedman, 1964) uses the
following equation;Please cite this article in press as: Hussain, M.A. et al., Fabricati
novel pullulan-aspirin conjugates. Arabian Journal of Chemistryln
da
dt
 
¼ lnZþ n lnð1 aÞ  Ea
RT
where, da/dt is the rate of weight loss directly taken from the
DTG curve; Z is the frequency factor of decomposition reac-
tion; n is the reaction order; 1a is the weight of sample left
at a certain temperature that is also taken from the TG curve;
Ea is the activation energy; R is the gas constant and T is the
absolute temperature recorded.The order of the reaction was
calculated from the Changmodel as given below (Chang, 1994).on, characterization, thermal stability and nanoassemblies of
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.06.001
4 M.A. Hussain et al.ln
d/
dt
ð1 /Þn
 
¼ lnZ Ea
RT
A straight line was obtained when ln [(da/dt)/(1a)n] was plot-
ted versus 1/T in case if the assumed n value is found correct.
The slope and intercept of the straight line were used to calcu-
late the Ea and Z values.
The Broido method (Broido, 1969) was also used to calcu-
late kinetic parameters, i.e., Ea and Z as per following
equation.
ln ln
1
y
 
¼  Ea
RT
þ Constant
where, y= (wtw1)/(w0w1), wt =weight at a given time t,
w0 = initial weight and w1 is ﬁnal weight.
3. Results and discussion
3.1. Synthesis and characterization
The MPDs of aspirin with a hydrophilic polysaccharide, i.e.,
pullulan, were synthesized using one pot and homogeneous
reaction conditions (Samples 1–4). Pre-dissolved pullulan5.06.07.08.09.0
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Figure 3 The 13C NMR (400 MHz, DMSO-d
Please cite this article in press as: Hussain, M.A. et al., Fabricati
novel pullulan-aspirin conjugates. Arabian Journal of Chemistrywas reacted with imidazolide of aspirin drug prepared after
activation of its carboxylic acid functional group with 1,10-car-
bonyldiimidazole (CDI). Reaction methodology is generalized
in Scheme 1.
Aspirin was ﬁrst activated with a fascinating RCOOH acti-
vating reagent CDI. CDI reacts with RCOOH of aspirin to
make its imidazolide. Imidazolide was then reacted with the
–OH functional groups of the anhydroglucose units (AGU)
of pullulan to generate ester linkage. In this way, ester conju-
gates as MPDs of aspirin were successfully synthesized. A base
imidazole was generated in situ that neutralizes the unreacted
drug therefore no extra base is needed during the reaction.
Pullulan-aspirin conjugates 1–4 were fabricated by using dif-
ferent mole ratios of the reactants (AGU:CDI:aspirin). The re-
sults of esteriﬁcation reactions are given in Table 1 for all
newly fabricated MPDs of aspirin onto pullulan.
Aspirin has been previously attached with another cellulose
derivative i.e., hydroxypropylmethylcellulose (HPMC).
Although, it was pioneering work for the attachment of aspirin
onto any ether derivative of cellulose the reaction resulted in
low DS of aspirin onto HPMC (Hussain et al., 2011a,b). The
DS of aspirin in HPMC-aspirin conjugates was obtained in
the range of 0.04–0.14. However, considerably high drug load-1.02.03.04.0
H-1-6 H-7
DMSO-d6
ppm
trum of pullulan-aspirin conjugate 1.
255075
C-9C-11-14
C-15
ppm
6) spectrum of pullulan-aspirin conjugate 1.
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Table 2 The results of thermal analysis and kinetics of aspirin, pullulan and pullulan-aspirin conjugate 3.
Sample Step Tdi, Tdm, Tdf Method R
2 n M (Slope) Ea (kJ/mol) lnZ Z (s
1)
Pullulan-aspirin conjugate I 135, 213, 289 Friedman 0.991 – 4189 34.83 6.905 9.9 · 102
Broido 0.999 – 5545 46.10 11.07 6.4 · 104
Chang 0.997 1 3998 33.24 6.605 7.4 · 102
II 316, 365, 411 Friedman 0.979 – 33,638 279.68 51.93 3.6 · 1022
Broido 0.999 – 32,961 274.05 51.48 2.3 · 1022
Chang 0.999 1 30,604 254.46 49.44 3.0 · 1021
III 529, 623, 643 Friedman 0.995 – 23,415 194.68 25.34 1.0 · 1011
Broido 0.999 – 27,357 227.45 31.00 2.9 · 1013
Chang 0.986 1 23,982 199.39 26.32 2.7 · 1011
Pullulan I 278, 320, 371 Friedman 0.988 – 32,497 270.19 53.72 2.1 · 1023
Broido 0.999 – 19,683 163.65 33.13 2.4 · 1014
Chang 0.999 1 18,537 154.13 32.63 1.5 · 1014
Aspirin I 134, 152, 189 Friedman 0.999 – 16,634 138.30 38.53 5.4 · 1016
Broido 0.991 – 19,598 162.95 45.46 5.5 · 1019
Chang 0.997 1 19,176 159.43 46.49 1.6 · 1020
Friedman 0.998 – 10,579 87.96 17.99 6.5 · 107
II 250, 327, 356 Broido 0.999 – 15,787 131.26 26.45 3.1 · 1011
Chang 0.999 1 12,568 104.5 21.71 2.7 · 109
Fabrication, characterization, thermal stability and nanoassemblies of novel pullulan-aspirin conjugates 5ing was achieved in the present study. Ds. was found in the
range of 0.32–0.40 for pullulan-aspirin conjugates with same
mole ratios of drug to polymer. This increased drug loading
can potentially reduce the size of dose.
Aspirin prodrugs synthesized by the CDI method were
found soluble in different organic solvents, i.e., DMSO,
DMF, acetone and DMA. The products were thoroughly char-
acterized by using different spectroscopic techniques. Thermo-
gravimetric (TG) analyses were used to determine the stability
of the fabricated MPDs. Transmission election microscopy
(TEM) was used to study nanoassemblies in solution. The de-
tailed structure characterization is given below.
Aspirin conjugates 1–4 have shown ester peaks in FTIR
spectra. The FTIR (KBr) spectrum of pullulan-aspirin conju-
gate 2 (Fig. 1) has shown ester absorptions at 1744, aromatic
C–H absorption at 2926 and unreacted –OH absorption at
3437 cm1. Nevertheless, pullulan-aspirin conjugates 1–4 have
displayed aromatic C–H absorptions, hydroxyl group absorp-
tion and CH2 (polymer) absorption signals as well in the FTIR
spectra that indicate the success of esteriﬁcation reactions.
The 1H NMR (400 MHz) spectra of pullulan-aspirin conju-
gates were recorded in DMSO-d6. The typical spectrum of
sample 1 (Fig. 2) showed the presence of the aromatic ring cou-
pled with pullulan polymer backbone as aromatic protons
were detectable at d 6.94–7.86 ppm. The aromatic H-9 and
H-11 overlapped and absorbed at d 6.94 ppm while H-8 and
H-10 absorbed at 7.86 and 7.50 ppm, respectively.Figure 4 The TG (LHS) and DTG (RHS) curves of aspirin
Please cite this article in press as: Hussain, M.A. et al., Fabricati
novel pullulan-aspirin conjugates. Arabian Journal of ChemistryThese results have demonstrated that the unsaturated sys-
tem is not destroyed during the entire course of the reaction.
Broad signals of aromatic protons also suggest the covalent
attachment of aromatic system onto different positions of hy-
droxyl groups in the pullulan polymer chains. Protons of
pullulan polymer backbone/anhydroglucose unit (AGU) were
detectable at 3.35–5.70 (AGU-H-1-6) ppm. The 1H NMR
spectrum has proved that samples fabricated by using the
CDI method are highly pure as no sign of any impurity is de-
tected in spectrum. The DS was also possible to be calculated
by the comparison of signal intensities of the aromatic ring
absorption with AGU-Hs. The DS of the samples 1–4 was
found in the range of 0.32–0.40 (see Table 1).
A typical 13C NMR spectrum of sample 1 recorded in
DMSO-d6 shows the characteristic signals at d 170.49 and
168.99 for the carbonyl absorptions of acetyl moiety onto aspi-
rin and ester (CO) linkage with the polymer, respectively indi-
cating success of the reaction (Fig. 3). It is common to observe
two or three signals of C-10 of three sugars of maltotriosyl unit
of the pullulan because of geometrically diverse environment.
Nevertheless, C-10 absorbed at 101.84 and 95.99 ppm for
pullulan-aspirin conjugate 1. The C-11-14 of pullulan maltotri-
ose unit appears in the range of 67.5–80.03 ppm. The 13C
NMR spectrum of pullulan-aspirin conjugate 1 is found com-
parable for maltotriose region with the NMR spectra of pullu-
lan nonaacetate (Tezuka, 1998), and pullulan abietates
(Hussain and Heinze, 2008).(- - -), pullulan (....) and pullulan-aspirin (__) conjugate 3.
on, characterization, thermal stability and nanoassemblies of
(2013), http://dx.doi.org/10.1016/j.arabjc.2013.06.001
Figure 5 TEM images of the pullulan-aspirin conjugate 3 showing nanoparticle formations in the range of 500–680 nm for majority of
the population.
6 M.A. Hussain et al.3.2. Thermal stability analysis of pullulan-aspirin conjugates
The initial decomposition (Tdi), maximum decomposition tem-
perature (Tdm) and ﬁnal decomposition (Tdf) of the pullulan-
aspirin conjugate 3 were assessed by thermogravimetry (TG)
and differential thermogravimetry (DTG) curves. The thermal
decomposition data of pullulan-aspirin conjugate 3 are shown
in Table 2 while the TG Curves and DTG thermograms of
sample 3 are shown in Fig. 4.
The thermograms of pullulan-aspirin conjugate 3 have
shown three-step degradation. The conjugate 3 was found
thermally stable up to 135 C (Tdi) with 14.2% weight loss
in overall ﬁrst step degradation. However Tdm and Tdf were
found at 213 and 289 C, respectively which are considerably
higher than pure aspirin (152, 189 C) indicating the extra sta-
bility imparted in pullulan-aspirin conjugate 3. The pullulan-
aspirin conjugate 3 has shown major degradation in step-II.
An overall weight loss of 67.68% was observed in this step.
A Tdm 365 C was observed for the conjugate 3 which is higher
than Tdm of step-II for pure aspirin (327 C). This result has
indicated that aspirin becomes 38 C more stable in conju-
gates. In step III, a slow degradation proceeds to completion
leaving behind 0.85% char yield at 643 C. It is concluded
from above mentioned results that pullulan-aspirin conjugates
are thermally more stable than pure aspirin and pullulan.
From thermogravimetric analysis, some kinetic parameters
like activation energy (Ea), order of reaction (n) and frequency
factor (Z) were determined. . To study the kinetic parameters
(Ea and Z) of thermal degradation, Friedmann and Broido
models were employed. The order of reaction n was calculated
by using the Chang model. The details on the kinetics and
comparison of the results are summarized in Table 2. The re-
sults have indicated comparable Ea values of the step-I degra-
dation of conjugate 3, i.e., 34.83, 46.10 and 33.24 kJ/mol as
calculated by Friedmann, Broido and Chang models, respec-
tively. Applying same models, aspirin has shown Ea values
138, 163 and 159 kJ/mol, for the relevant ﬁrst step. The n
was calculated through the Kissinger model which indicated
the ﬁrst order kinetic of the said degradation steps. The conju-
gate 3 has shown Ea values of 280, 274 and 254 kJ/mol, respec-
tively for step-II degradation, while pure aspirin showed Ea
values 88, 131 and 104 kJ/mol, respectively for step-II. As all
the Ea values are not very high therefore it is roughly estimated
that degradation generally follows ﬁrst order kinetics. It is
noted from Table 2 that the application of different kinetic
models on the TG curves gives almost comparable results.Please cite this article in press as: Hussain, M.A. et al., Fabricati
novel pullulan-aspirin conjugates. Arabian Journal of Chemistry3.3. Transmission electron microscopy (TEM)
The TEM analyses were carried out to study the behavior of
pullulan-aspirin conjugates in solution by the solvent diffusion
method. The TEM images of the molecular self-assembly have
revealed the formation of nanoparticles in case of sample 3
(Fig. 5) in the range of 500–680 nm for the major population
of nanoparticles. Nanoparticle formation is indicative of the
fact that there lies a very good balance of hydrophobicity
and hydrophilicity in sample 3 that favored the formation of
nanoparticles of the water soluble biopolymer pullulan. Such
nanoparticulate drug design for aspirin MPDs onto pullulan
may lead to improved pharmacokinetic proﬁle of aspirin.
4. Conclusion
A water soluble and biocompatible polysaccharide, i.e., pullu-
lan was successfully evaluated to be used as a valuable covalent
drug carrier for NSAIDs, i.e., aspirin. The newly synthesized
MPDs of aspirin appeared thermally highly stable and org-
ano-soluble. All of the products were highly pure and thor-
oughly characterized. Pullulan-aspirin conjugates self-
assemble in nanoparticles in useful size regimen, therefore, said
novel MPDs of aspirin could be highly potent for its better
pharmacokinetic proﬁle and controlled release of aspirin.Acknowledgement
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